GLS and cancer: CDP-3B (Hexylselen, 26, Figure 13) is a seleno derivative inhibitor of KGA/glutamate dehydrogenase (GDH) that completely inhibited the cancer cell growth of many aggressive tumors, reduced the tumor size in an aggressive liver cancer xenograft model, and showed no toxic effects on normal cells at a concentration of up to 10 μM.